Trial intelligence / Profile preview

Hyperpolarized Xenon MRI for Brown Adipose Tissue Detection

NCT02220426Phase 1Terminated

Sponsor
University of North Carolina at Chapel Hill
Start
Sep 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of xenon in obesity, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Brown Adipose Tissue Surface Area at Day 1. Started Sep 2015; status: terminated.

02

Drugs

xenon
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02220426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02220426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call